Abstract:Purpose: Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders, posing a serious threat to the health of women. Herein, we aimed to explore new biomarkers and potential therapeutic targets for PCOS by employing integrated bioinformatics tools. Methods: Three gene expression profile datasets (GSE138518, GSE155489, GSE106724) were obtained from the Gene Expression Omnibus database and the differentially expressed genes in PCOS and normal groups with an adjusted p-value < 0.05 and a |log fold change (FC) | > 1.2 were first identified using the DESeq package. The weighted correlation network analysis (WGCNA) R package was used to identify clusters of highly correlated genes or modules associated with PCOS. Protein-protein interaction (PPI) network analysis and visualization of genes in the key module were performed using the STRINGdb database and the NetworkX package (edge > 5), respectively. The genes overlapping among the key module genes and PCOS-associated genes were further analyzed. Ligand molecules with strong binding energy < -10 kJ/mol to GNB3 were screened in the drug library using MTiOpenScreen. AutoDock, ChimeraX, and BIOVIA Discovery Studio Visualizer were further used to elucidate the mechanism of ligand interaction with GNB3. Finally, the relationship between GNB3 and PCOS was verified using experimental models in vivo and in vitro. Results: Of the 11 modules identified by WGCNA, the black module had the highest correlation with PCOS (correlation = 0.96, P = 0.00016). The PPI network of 351 related genes revealed that VCL, GNB3, MYH11, LMNA, MLLT4, EZH2, PAK3, and CHRM1 have important roles in PCOS. The hub gene GNB3 was identified by taking the intersection of PCOS-related gene sets. MTiOpenScreen revealed that five compounds interacted with GNB3. Of these five, compound 1 had the strongest binding ability and can bind amino acids in the WD40 motif of GNB3, which in turn affects the function of the G protein-coupled receptor β subunit. GNB3 was also significantly downregulated in PCOS models. Conclusion: We identified the hub gene GNB3 as the most important regulatory gene in PCOS. We suggest that compound 1 can target the WD40 motif of GNB3 to affect related functions and must be considered as a lead compound for drug development. This study will provide new insights into the development of PCOS-related drugs.

Identification of the Hub Genes in Polycystic Ovary Syndrome Based on Disease‐associated Molecule Network

Aberrant Expression and DNA Methylation of Lipid Metabolism Genes in PCOS: a New Insight into Its Pathogenesis.

Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome

Identification of Potential Biomarkers of Polycystic Ovary Syndrome Via Integrated Bioinformatics Analysis

Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome

Identification of CCR7 As a Potential Biomarker in Polycystic Ovary Syndrome Through Transcriptome Sequencing and Integrated Bioinformatics

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins

Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome

Identification of the Shared Gene Signatures and Pathways Between Polycystic Ovary Syndrome and Endometrial Cancer: an Omics Data Based Combined Approach.

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

From proteome to pathogenesis: investigating polycystic ovary syndrome with Mendelian randomization analysis

Identification and validation of core genes associated with polycystic ovary syndrome and metabolic syndrome

Several critical genes and microRNAs associated with the development of polycystic ovary syndrome

The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray

Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis

Computational Characterization and Identification of Human Polycystic Ovary Syndrome Genes

Identifying Novel Genetic Loci Associated with Polycystic Ovary Syndrome Based on Its Shared Genetic Architecture with Type 2 Diabetes.

Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China

Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer through Bioinformatics

The Differential Expression Profile of Polycystic Ovary Syndrome Associated Genes